Inflection Delayed But IBM Still Has Upside
Northlake has been monitoring IBM for some time in anticipation of an inflection point in the company’s revenue growth and margin profile. We purchased the shares last quarter thinking that the 3Q19 and 2H19 would provide the inflection and lead to a higher P-E multiple for the shares. At our entry point and currently IBM […]
